Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients.

World J Gastroenterol

Department of Hepatology, Hangzhou Xixi Hospital, Zhejiang University School of Medicine, Hangzhou 310023, Zhejiang Province, China.

Published: July 2024

This letter to the editor relates to the study entitled "Tenofovir amibufenamide tenofovir alafenamide for treating chronic hepatitis B: A real-world study", which was recently published by Peng . Hepatitis B virus infection represents a significant health burden worldwide and can lead to cirrhosis and even liver cancer. The antiviral drugs currently used to treat patients with chronic hepatitis B infection still have many side effects, so it is crucial to identify safe and effective drugs to inhibit viral replication.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11287400PMC
http://dx.doi.org/10.3748/wjg.v30.i26.3261DOI Listing

Publication Analysis

Top Keywords

chronic hepatitis
12
effectiveness safety
4
safety tenofovir
4
tenofovir amibufenamide
4
amibufenamide chronic
4
hepatitis
4
hepatitis patients
4
patients letter
4
letter editor
4
editor relates
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!